In response to FDA's request for information on the labeling of (future) food products derived from cell-cultured seafood, CSPI submitted this comment on March 8, 2021.

In CSPI's view, when cell-cultured seafood products are ready for their food safety assessment at FDA, the agency, with stakeholder input, should identify material differences from traditional products and then make consumers aware of those differences on the product label. The comment lays out several potential material differences that would be of interest to consumers.

View resource